AI reshapes drug R&D, but limits remain

Panelists said the industry is still in the early stages of integrating AI into research and development.

Staff Reporter•Apr 30, 2026 06:59 AM• 9 views

Panelists for the AI in BioPharma R&D - Hype vs. Reality panel

Credit: USAIC

Author